drugset / Trial / NCT01615250

Implantation of Peripheral Stem Cells in Patient With Ischemic Cardiomyopathy

NCT01615250 ↗

Phase 1 Unknown 50 enrolled Odessa National Medical University
RandomizedSingle-groupOpen-labelTreatment

Summary

This is a randomized study of efficiency and safety of intramyocardial implantation of peripheral mononuclear cells with high concentration of CD34+ stem cells in patients with myocardial ischemia after preparatory course of shock - wave therapy.

Timeline

Start
2012-01
Primary completion
2015-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator autologous peripheral mononuclear cells with CD34+ stem cells Cell therapy 2e+08 cells Other

Indications